Albemarle (ALB) Competitors

AdvanSix has lower revenue, but higher earnings than Albemarle. Albemarle is trading at a lower price-to-earnings ratio than AdvanSix, indicating that it is currently the more affordable of the two stocks.

AdvanSix has a net margin of 0.67% compared to Albemarle's net margin of -5.00%. Albemarle's return on equity of 5.22% beat AdvanSix's return on equity.

Albemarle has a beta of 1.34, suggesting that its share price is 34% more volatile than the broader market. Comparatively, AdvanSix has a beta of 1.3, suggesting that its share price is 30% more volatile than the broader market.

Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 1.2%. AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 3.2%. Albemarle pays out -47.5% of its earnings in the form of a dividend. AdvanSix pays out 173.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Albemarle has raised its dividend for 30 consecutive years and AdvanSix has raised its dividend for 2 consecutive years.

In the previous week, Albemarle had 15 more articles in the media than AdvanSix. MarketBeat recorded 15 mentions for Albemarle and 0 mentions for AdvanSix. Albemarle's average media sentiment score of 0.82 beat AdvanSix's score of 0.00 indicating that Albemarle is being referred to more favorably in the media.

Albemarle currently has a consensus target price of $199.58, suggesting a potential upside of 47.55%. AdvanSix has a consensus target price of $22.50, suggesting a potential upside of 11.05%. Given Albemarle's stronger consensus rating and higher probable upside, equities research analysts plainly believe Albemarle is more favorable than AdvanSix.

92.9% of Albemarle shares are owned by institutional investors. Comparatively, 86.4% of AdvanSix shares are owned by institutional investors. 0.4% of Albemarle shares are owned by insiders. Comparatively, 5.0% of AdvanSix shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cabot has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market. Comparatively, Albemarle has a beta of 1.34, meaning that its stock price is 34% more volatile than the broader market.

Cabot has a net margin of 7.97% compared to Albemarle's net margin of -5.00%. Cabot's return on equity of 21.33% beat Albemarle's return on equity.

93.2% of Cabot shares are owned by institutional investors. Comparatively, 92.9% of Albemarle shares are owned by institutional investors. 3.1% of Cabot shares are owned by insiders. Comparatively, 0.4% of Albemarle shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Cabot currently has a consensus target price of $85.80, suggesting a potential downside of 0.57%. Albemarle has a consensus target price of $199.58, suggesting a potential upside of 47.55%. Given Albemarle's stronger consensus rating and higher probable upside, analysts clearly believe Albemarle is more favorable than Cabot.

In the previous week, Albemarle had 14 more articles in the media than Cabot. MarketBeat recorded 15 mentions for Albemarle and 1 mentions for Cabot. Albemarle's average media sentiment score of 0.82 beat Cabot's score of 0.00 indicating that Albemarle is being referred to more favorably in the news media.

Cabot has higher earnings, but lower revenue than Albemarle. Albemarle is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.2%. Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 1.2%. Cabot pays out 35.7% of its earnings in the form of a dividend. Albemarle pays out -47.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has raised its dividend for 14 consecutive years and Albemarle has raised its dividend for 30 consecutive years.

Albemarle has a net margin of -5.00% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Albemarle's return on equity.

Chemours presently has a consensus price target of $24.10, indicating a potential upside of 26.98%. Albemarle has a consensus price target of $199.58, indicating a potential upside of 47.55%. Given Albemarle's stronger consensus rating and higher probable upside, analysts clearly believe Albemarle is more favorable than Chemours.

In the previous week, Albemarle had 11 more articles in the media than Chemours. MarketBeat recorded 15 mentions for Albemarle and 4 mentions for Chemours. Albemarle's average media sentiment score of 0.82 beat Chemours' score of -0.08 indicating that Albemarle is being referred to more favorably in the news media.

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 1.8%. Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 1.2%. Chemours pays out -13.3% of its earnings in the form of a dividend. Albemarle pays out -47.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Albemarle has increased its dividend for 30 consecutive years.

Chemours has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market. Comparatively, Albemarle has a beta of 1.34, meaning that its stock price is 34% more volatile than the broader market.

76.3% of Chemours shares are held by institutional investors. Comparatively, 92.9% of Albemarle shares are held by institutional investors. 0.9% of Chemours shares are held by insiders. Comparatively, 0.4% of Albemarle shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Chemours has higher revenue and earnings than Albemarle. Albemarle is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.

Albemarle has lower revenue, but higher earnings than Celanese. Albemarle is trading at a lower price-to-earnings ratio than Celanese, indicating that it is currently the more affordable of the two stocks.

Albemarle has a net margin of -5.00% compared to Celanese's net margin of -11.54%. Celanese's return on equity of 9.92% beat Albemarle's return on equity.

In the previous week, Albemarle had 8 more articles in the media than Celanese. MarketBeat recorded 15 mentions for Albemarle and 7 mentions for Celanese. Albemarle's average media sentiment score of 0.82 beat Celanese's score of 0.44 indicating that Albemarle is being referred to more favorably in the news media.

Celanese has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market. Comparatively, Albemarle has a beta of 1.34, meaning that its share price is 34% more volatile than the broader market.

Celanese pays an annual dividend of $0.12 per share and has a dividend yield of 0.3%. Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 1.2%. Celanese pays out -1.2% of its earnings in the form of a dividend. Albemarle pays out -47.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Albemarle has increased its dividend for 30 consecutive years. Albemarle is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Celanese presently has a consensus price target of $65.69, indicating a potential upside of 37.94%. Albemarle has a consensus price target of $199.58, indicating a potential upside of 47.55%. Given Albemarle's stronger consensus rating and higher possible upside, analysts plainly believe Albemarle is more favorable than Celanese.

98.9% of Celanese shares are owned by institutional investors. Comparatively, 92.9% of Albemarle shares are owned by institutional investors. 0.3% of Celanese shares are owned by insiders. Comparatively, 0.4% of Albemarle shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.